In November 2020, the state of Oregon passed a new measure that allows people to participate in legal psilocybin sessions. Search this directory to find Oregon Psilocybin Service Centers. People are excited to take advantage of this new law, but there are some things you should know before participating. Let’s talk about where you can get legal psilocybin in Oregon.
In the last few decades, psilocybin and other psychedelics have been shown to be helpful for people with depression, anxiety, and more. Despite its association with the “hippie” counterculture, psilocybin and other psychedelics are gaining credibility in the medical field through clinical research and rapidly gaining interest from the public.
Some researchers believe psilocybin could be one of the most effective psychedelics for treating mental health disorders [1]. In mood disorders such as depression, psilocybin could be a great tool to ease symptoms and improve the lives of patients substantially. Psilocybin has shown pain management benefits as well as mental ones. In clinical trials, it’s proved to be a helpful analgesic for migraines, chronic pain, and phantom limb pain2.
Perhaps most importantly, psilocybin is generally safe. Of all psychedelics, it’s thought to be the safest from a physiological point of view. The Registry of Toxic Effects of Chemical Substances gives psilocybin a safety profile better than nicotine and aspirin1. It has little potential for abuse or addiction and is generally well-tolerated in a controlled environment.
Given the positive evidence for safety and efficacy, we’re excited to see Oregon’s initiative to help people take advantage of psilocybin as a tool for self-growth and healing. Let’s talk about what this bill means.
Follow your Curiosity
Sign up to receive our free psychedelic courses, 45 page eBook, and special offers delivered to your inbox.Is Psilocybin Legal in Oregon?
Decriminalization and Access
As part of the 2020 bill, Oregon decriminalized psilocybin. Other cities and states have decriminalized psychedelics, starting with Denver in 2019. Oregon was the first state to not only decriminalize the substance but to regulate and make it available for the public. Now, Colorado has legal centers to access psilocybin.
This is exciting news for the state of Oregon, which has some of the highest rates of mental illness in the nation3. Nearly one in five adults in Oregon has a mental illness. The governor has declared a public health crisis due to the prevalence of addiction in the state. Between 2019 and 2021, the state planned to spend 2.8 billion on behavioral and mental health programs.
By creating this bill, Oregon is aiming to help not only people with mental health diagnoses but anyone who wishes to take part in facilitated psilocybin sessions. Unlike the medical card system for marijuana, anyone 21 and up will be able to experience psilocybin in certified service centers.
Where can I get psilocybin therapy in Oregon?
It is now possible to sign up to participate in legal psilocybin sessions in Oregon. Since 2023, certified psilocybin centers have been operating. The Oregon Health Authorirty’s website has a directory of service centers.
Before anyone can open a psilocybin service center, licenses have to be applied for and approved by the advisory committee. Oregon began taking license applications for service centers, training programs, manufacturers, and laboratories on January 2, 2023. It’s uncertain how long the licensure process can take, as each licensed service center will manage its own operations including communications, waiting lists, and scheduling with clients.
Psilocybin Session Overview
The psilocybin experience has 3 parts – preparation, psilocybin dosing session, and a follow-up. To undergo a facilitated psilocybin session, you will first need to contact a psilocybin service center. If you are possibly eligible to receive psilocybin, you will next schedule a preparation session before taking psilocybin. Here is what the process looks like:
- During the preparation session, you will fill out an information form, undergo an informed consent, review a client bill of rights, receive safety and support planning, transportation planning, and have a discussion with a licensed facilitator. Preparatory sessions may be completed in person or virtually via video call. As part of the preparatory session, you will work with a facilitator to understand the dosage to take which can range from a low to high dose.
- Your faciliated psilocybin session will take place at one of Oregon’s licensed psilocybin service centers. When you arrive, you’ll purchase your psilocybin products directly from the center and take them at the start of your session under professional supervision. You’ll remain at the facility with your licensed facilitator throughout the entire experience until you’re feeling stable and ready to leave safely (up to 6 hours after dosing). If you’re participating in a group session, Oregon law ensures there are enough facilitators present to maintain proper supervision ratios.
- Within three days after your session, your facilitator will reach out to check on how you’re doing and see if you need any support. You’ll also have the option to schedule follow-up integration sessions to help you process and make sense of your experience. You may wish to work with a licensed health professional for integration – search our vetted provider directory here.
Psilocybin Dosage
Oregon’s psilocybin service centers operate under strict dosing regulations that limit the amount of psilocybin clients can receive per session. Under current regulations, this equates to a maximum of 50 mg of psilocybin analyte per session (with the average dose for Q1 2025 reported at 24.44 mg). You may try any amount up to 50 mg of psilocybin during an administration session, with the dosing range spanning from as low as 5 mg to the maximum 50 mg limit. This dosing framework applies to both individual and group sessions, and the specific amount within this range is determined through consultation between you and the licensed facilitator based on your experience level, therapeutic goals, and medical history. The state’s regulations focus on the weight of pure psilocybin compound rather than the total weight of mushroom material, ensuring consistent and controlled dosing across all licensed service centers.

What to Know About Oregon’s Psilocybin Services
We’re excited for Oregon Psilocybin Services to provide access to legal psilocybin. As of 2025, there are 27 licensed centers operating statewide. There are several important things to note about these services, which refer to preparation, administration, and integration sessions provided by a licensed facilitator.
- Psilocybin is still a Schedule 1 drug under the FDA. This legislation does not protect licensees or users from federal law. We’re not sure how this will affect users and facilitators.
- You won’t be able to get psilocybin for private or home use. This bill grants access to psilocybin for licensed distributors to be used in the context of facilitated psilocybin sessions. Participants will be able to take part in psilocybin journeys in controlled environments (“service centers”) under the supervision of licensed service facilitators.
- A licensed manufacturer cultivates and processes the psilocybin products that are used. Products may be consumed as dried whole mushrooms, extracts, or powdered mushrooms that can be put into capsules or stirred into tea or edibles such as chocolate and other edible food products. Only natural psilocybin products are allowed (so synthetic psilocybin cannot be used, as it is in clinical trials). During the preparatory session, the client will work with the facilitator to understand and decide on the product type. All products are tested by licensed laboratories. After testing requirements are met, licensed manufacturers can send the packaged products to a licensed service center. Throughout this process, the products are tracked in a state-tracking system.
- The state or insurers will not fund psilocybin sessions. The cost of psilocybin therapy will vary depending on the service center. In 2025, the cost for psilocybin sessions ranged from $1,200 to $3,000 for individuals or starting at $750 for a group.
- The state of Oregon has voiced its commitment to providing access to as many people as possible, but there will still probably be an up-front cost. Oregon Psilocybin Services (OPS), a section of the OHA that issues licenses to service centers, aims to align with the goals of Oregon’s State Health Improvement Plan, which advances health equity for priority populations, including Black, Indigenous, people of color, tribal communities, people with low incomes, people who identify as LGBTQIA2S+, people with disabilities, and people living in rural areas.
- A federal lawsuit filed in 2024 against the Oregon Health Authority is challenging the state’s psilocybin services program under the Americans with Disabilities Act (ADA), alleging that the state Psilocybin Services Act (PSA) discriminates against disabled individuals who can’t travel to designated service centers. The lawsuit argues that Oregon’s requirement that psilocybin therapy only be administered at licensed service centers creates an illegal barrier for homebound patients with disabilities who cannot physically access these facilities.
Accessibility Challenges
The high costs are creating accessibility barriers. Out of the clients who disclosed their income, the majority made more than $95,000 per year, indicating the therapy is primarily accessible to wealthier individuals. Insurance typically doesn’t cover these services since psilocybin remains federally illegal.
Several factors contribute to the high pricing:
- The state charges owners $10,000 a year for a license for service centers.
- Training programs typically range from $6,000 to $12,000 for facilitators.
- Facilitators must also pay between $1,000 and $2,000 annually for licensing.
The state doesn’t regulate pricing, allowing each licensed service center to set their own rates.
From Therapists to Facilitators
People have raised concerns over the bill’s wording since the vote was passed. At first, we thought it would be offered as a therapeutic regimen under the strict supervision of a licensed therapist. However, these therapists wouldn’t be protected from liability from the state or insurance. It would be hard or impossible to find therapists willing to practice without protection.
Since passing, the bill has been re-framed as sessions supervised by facilitators. In terms of access, this may help more people get access to psilocybin. However, facilitators will not be licensed in mental health or educated like therapists are, and they are not meant to diagnose or treat mental health conditions as part of their role, as this would be additional licensure. Facilitators may hold other professional licenses in Oregon but are not allowed to practice on those licenses while providing preparation, administration, or integration sessions to clients. The statute states that a licensed facilitator must take a non-directive approach to facilitating psilocybin services, which is supporting a safe, client-led experience.
It should be underscored, however, that therapists may still play an important role in the preparation and integration process. Read this fact sheet for information on requirements, steps, and access to become a licensed psilocybin services facilitator in Oregon.
Advocacy and Legislative Progress
We’re still excited about improved access to psilocybin. This bill would not have been brought up for a vote without the advocacy of Sheri and Thomas Eckert. They’ve been working to pass psilocybin therapy legislation for the last several years. Both are therapists in Oregon and believe strongly that psilocybin can help people better than pharmaceutical therapy. In a 2017 interview with The Oregonian, Thomas Eckert said, “Where typically pharma-type interventions fall short, psilocybin is really breaking through with pretty amazing frequency”4.
Shaping the Psilocybin Landscape
In November 2020, the state of Oregon passed Ballot Measure 109. This established a new regulatory body under the Oregon Health Authority (OHA): The Oregon Psilocybin Advisory Board (OPAB). Thomas Eckert heads this group and will develop a regulatory framework for the state.
Sadly, Sheri Eckert passed away soon after this vote. A new foundation has been formed in her honor to continue her important work of creating “equitable access to psychedelic education and services”. Her husband Thomas continues to work towards her vision by heading up the advisory board and leading the implementation of this new law in Oregon. Learn more about Sheri’s foundation at sherieckert.org.
Between January 2021 and December 2022, the board was tasked with standardizing the manufacture, transportation, delivery, sale, and purchase of psilocybin in the state of Oregon. It also developed a system to track the manufacture, sale, purchase, and transfer of psilocybin so that it won’t be transported into other states.
Manufacturers have specific guidelines and standards and need licenses before starting to make psilocybin. Facilitators who will guide psilocybin sessions need licenses as well. Service centers will host psilocybin sessions and will also need to get licensure before offering these services.
Is Psilocybin Right for Me?
Only you can know if psilocybin can work for you. And it’s not right for everyone. For instance, people with a history of psychosis and mania may be triggered by psychedelic substances. By developing a relationship with a trained psychedelic therapist, together you can make the decision to pursue psilocybin therapy.
There are specific diagnoses that psilocybin has been especially helpful for so far. Psilocybin has proven itself to be a useful tool for depression. It’s given relief even for people suffering from major depressive disorder and treatment-resistant depression5. One study even compared psilocybin with escitalopram (Lexapro), an antidepressant. Even though psilocybin was given once, and Lexapro was taken every day, psilocybin performed better in the long term6.
We’re still early in the process of understanding the potential for psilocybin and other psychedelic therapies. The body of research and legislation on psilocybin is growing rapidly. Who knows what other diagnoses could be treated with psilocybin therapy? Check back in on our articles page to stay up-to-date on the latest research and laws on this exciting subject.
Learn more about choosing therapy on our blog. To understand whether psilocybin could be a good fit, you can search for a psychedelic provider on our search page. If you are a practitioner wanting to offer your patients the healing benefits of psilocybin and other psychedelic drugs, take a look at our free resources and paid courses.
This article was originally published on January 14, 2022.
References
- Lowe, H., Toyang, N., Steele, B., Valentine, H., Grant, J., Ali, A., Ngwa, W., & Gordon, L. (2021). The therapeutic potential of psilocybin. Molecules, 26(10), 2948. https://doi.org/10.3390/molecules26102948
- Griffiths, R. R., Richards, W. A., McCann, U., & Jesse, R. (2006). Psilocybin can occasion mystical-type experiences having substantial and sustained personal meaning and spiritual significance. Psychopharmacology, 187(3), 268–283. https://doi.org/10.1007/s00213-006-0457-5
- Published: Dec 13, 2021. (2021, December 13). Mental health and substance use state fact sheets. KFF. Retrieved December 21, 2021, from https://www.kff.org/statedata/mental-health-and-substance-use-state-fact-sheets/oregon/#:~:text=The%20
- Acker, L. (2017, December 5). This couple wants to make it legal to use psychedelic mushrooms in Oregon. The Oregonian.
- Davis, A. K., Barrett, F. S., May, D. G., Cosimano, M. P., Sepeda, N. D., Johnson, M. W., Finan, P. H., & Griffiths, R. R. (2021). Effects of psilocybin-assisted therapy on major depressive disorder. JAMA Psychiatry, 78(5), 481. https://doi.org/10.1001/jamapsychiatry.2020.3285
- Carhart-Harris, R., Giribaldi, B., Watts, R., Baker-Jones, M., Murphy-Beiner, A., Murphy, R., Martell, J., Blemings, A., Erritzoe, D., & Nutt, D. J. (2021). Trial of psilocybin versus escitalopram for depression. New England Journal of Medicine, 384(15), 1402–1411. https://doi.org/10.1056/nejmoa2032994